DUBLIN, August 10, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Cancer Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Cancer Diagnostics Market is poised to grow at a CAGR of around 11.7% over the next decade to reach approximately $22.7 billion by 2025.
This industry report analyzes the global markets for Cancer Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Technically Advanced devices
3.1.2 Increase in Health care infrastucture
3.1.3 Economical and better outcome
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
4 Cancer Diagnostics Market, By Technology
4.4 Tumor Biomarker Tests
5 Cancer Diagnostics Market, By Application
5.1 Blood Cancer
5.2 Colorectal Cancer (CRC)
5.4 Lung Cancer
5.5 Breast Cancer
5.6 Kidney Cancer
5.7 Prostate Cancer
5.8 Pancreatic Cancer
5.9 Ovarian Cancer
6 Cancer Diagnostics Market, By Geography
7 Leading Companies
- Agilent Technologies, Inc.
- Ambry Genetics
- AstraZeneca plc
- Becton, Dickinson and Company
- C.R. Bard, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GE Healthcare (A Subsidiary of General Electric Company)
- Illumina, Inc.
- Pfizer, Inc.
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
- bioMeriux SA
For more information visit http://www.researchandmarkets.com/research/g9wlp9/global_cancer
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets